Background: Patients with coronary artery disease and prior percutaneous coronary intervention
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INTRODUCTION
Approximately 20% of patients who undergo percutaneous coronary intervention (PCI) require non-cardiac surgery in the subsequent two years. (1-3) Optimal risk stratification of these patients is crucial, as they represent a high-risk subset of patients who are more likely to experience adverse postoperative events compared to the overall population of patients undergoing non-cardiac surgery. (4-7) Current guidelines for perioperative management have suggested optimal control of risk factors and delaying surgery for a year among patients with drug-eluting stents, but de-emphasize the need for stress testing or evaluation for underlying ischemia in the absence of symptoms. (8,9)
While both patient and lesion-related factors contribute to the risk of non-cardiac surgery among patients with prior PCI, the attributable risk from incomplete revascularization and presumed residual ischemia remains uncertain. (10) It is known that residual ischemia in patients with stable CAD is a risk factor for long-term adverse cardiovascular events, and that patients treated with anatomic complete revascularization (either surgically or percutaneously) have lower cardiovascular event rates. (11-14) More recently, anatomic scoring systems have also suggested an association between incomplete anatomic revascularization after PCI and major adverse cardiovascular events (15, 16) . Residual ischemia and incomplete revascularization may similarly represent significant risk factors for patients undergoing surgery, however the prevalence and outcomes of patients with incomplete revascularization undergoing noncardiac surgery is not well described.
We hypothesized that patients who had incomplete revascularization and presumed residual ischemia would be at increased risk for major adverse cardiovascular events when undergoing subsequent non-cardiac surgery, and that this risk would be independent of other M A N U S C R I P T
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MEDTHODS
Study Design and Study Population. This was a retrospective cohort study of patients who underwent non-cardiac surgery within two years after coronary stent placement. Patients with a prior history of coronary artery bypass grafting were excluded from the cohort. Coronary artery stent placement was identified using the VA Clinical Assessment, Reporting, and Tracking (CART) system. All coronary stents implanted in VA facilities between 2005-2010 were identified using data elements derived directly from the CART database, which includes prespecified fields for bare metal stents as well as the type of drug eluting stent.
Subsequent non-cardiac surgery occurring up to 24 months after coronary stent placement was identified using the VA Surgical Quality Improvement Program database (VASQIP); non-cardiac surgery outside of the VA was identified using the Centers for Medicare & Medicaid Services (CMS) database as previously described. (2) Surgeries performed during the same hospitalization as the initial PCI or after an intervening cardiac surgery or placement of a stent at a non-VA facility were excluded. The type of non-cardiac surgery performed was identified using current procedural terminology (CPT) codes 10000-32999 and 34000-69999.
Minor surgeries, including endoscopy and outpatient musculoskeletal injections, were excluded. Surgery types were also grouped by organ system and by elective vs. non-elective status.
The study protocol was reviewed and approved by the local VA institutional review board of each coauthor with waiver of informed consent. Procedural elements of the initial PCI were derived from CART data entered at the time of the procedure. These variables included the indication for the PCI (acute coronary syndrome with myocardial infarction, acute coronary syndrome without myocardial infarction, or stable angina), the stent type implanted (BMS, DES, or both), target vessel (left main, LAD, RCA, or circumflex), target lesion location (ostial, proximal, mid, or distal within given vessel), presence of significant lesion calcification, presence of lesion at a bifurcation, lesion length, intervention to chronic total occlusion, use of intravascular ultrasound, PCI risk, number of target vessels, stent length, largest stent diameter, and the anticoagulant used during PCI. Incomplete anatomic revascularization was defined as the presence of a ≥50% lesion in the left main coronary artery or ≥70% stenosis in another major epicardial coronary artery ≥2 mm in diameter at the conclusion of the PCI, based on visual estimate by the operator. All of the procedural variables were entered by the treating physician at the time of the intervention and were based on physician judgment at the time of the procedure. The patient's cardiac risk at the time of non-cardiac surgery using the revised cardiac risk index was estimated using ICD-9 codes for congestive heart failure, stroke, MI, and diabetes;
CPT codes associated with high-risk surgery; and laboratory data identifying one or more serum creatinine values greater than 2 mg/dL in the year prior to surgery. time from PCI and outcomes after non-cardiac surgery was identified that persisted even after adjusting for potential confounders. Therefore, the association of incomplete revascularization with postoperative MACE and MI was stratified based on the time from PCI to non-cardiac surgery. All analyses were completed using SAS version 9.2 (SAS institute).
RESULTS
During the study period, 12,486 patients without a history of coronary artery bypass grafting underwent PCI and subsequent non-cardiac surgery (Figure 1 ). 4,332 patients (34.7%) had incomplete anatomic revascularization. The baseline demographics of patients with and without incomplete revascularization are summarized in Table 1 . Patients with incomplete revascularization were more likely to have had a myocardial infarction in the prior six months (13.9% vs. 10.5%, p<0.001), were more likely to have a history of congestive heart failure (39.1% vs. 32.8%, p<0.001), and were more likely to have diabetes (57.9% vs. 52.8%, p<0.001).
Patients with incomplete revascularization were also slightly more likely to have undergone a PCI within the prior year (71.7% vs. 69.8%, p=0.03)
The angiographic characteristics of the index PCI are detailed in Table 2 . Patients with incomplete revascularization were more likely to have been treated for an acute coronary syndrome (71% vs. 64.6%, p<0.001), but had a similar distribution of target vessels compared to patients with complete revascularization. Patients with incomplete revascularization were on M A N U S C R I P T
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8 average treated with more coronary artery stents and were more likely to have an overall treatment length >30 mm, suggesting a greater burden of atherosclerotic disease among the patients who had incomplete revascularization. Table 3 details the unrevascularized vessels among patients with incomplete revascularization. The RCA (18%) and the LAD (17.9%) were the vessel most frequently associated with incomplete revascularization, while the circumflex (11.3%) and posterior descending artery (3%) were less frequently associated with incomplete revascularization. The prevalence of any chronic total occlusion in the non-target vessel among patients with incomplete revascularization was 1.3%.
11.1% of the cohort underwent preoperative stress testing in the three months prior to noncardiac surgery. There was no association between incomplete revascularization and the decision to perform preoperative stress testing (10.7% vs. 11.3%, p=0.4). Tables 4 and 5 Consistent with this time to surgery interaction, the overall rates of postoperative MI were significantly higher at early and late time points among patients with incomplete revascularization (Figure 4 ). There was no significant interaction between stent type and the risk of postoperative MACE based on these different time points, suggesting that the early and late risks of postoperative MACE were not dependent on the type of stent implanted (p=0.09 for interaction).
DISCUSSION
Patients with coronary artery disease and prior PCI who undergo non-cardiac surgery have a significantly increased risk of postoperative adverse events when compared to the general population. (4, 5) In this study, we found that incomplete revascularization among patients with prior PCI was associated with a significantly increased rate of postoperative MACE as a composite outcome and postoperative myocardial infarction as a component of MACE. We also observed a stepwise association between the number of vessels that were not revascularized and the risk of postoperative myocardial infarction, suggesting that greater ischemic burden was associated with an increased risk of postoperative MI. There was also a significant interaction M A N U S C R I P T
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Noncardiac surgery may result in postoperative MI due to numerous mechanisms, including plaque rupture from a pro-inflammatory state, stent thrombosis as a result of antiplatelet interruption, or a so-called demand event due to hemodynamic stress in the setting of a fixed stenosis (Type 2). (17) While we could not adjudicate the classification of MI category in our cohort, the majority of such events attributable to incomplete revascularization are presumably related to a Type 2 myocardial infarction in the setting of angiographically significant residual stenosis. Recent evidence suggests that Type 2 MI is associated with significantly worse adverse outcomes than previously recognized, with a two-fold increased rate of MACE and cardiovascular death when compared to patients without Type 2 MI. (18, 19) These findings suggest that mechanisms to risk stratify patients at risk of postoperative MI would minimize the long-term morbidity among patients with coronary artery disease undergoing noncardiac surgery.
Consistent with our primary finding that incomplete revascularization was associated with an increased risk of postoperative MACE and MI, we also observed a dose-response effect between the number of unrevascularized vessels and the risk of postoperative MI, with a 17% increased odds of postoperative MI for each additional vessel that was not revascularized. This finding suggests that a greater atherosclerotic and ischemic burden was associated with an increased risk of adverse events. Consistent with this hypothesis, the nuclear substudy of the COURAGE trial, patients with continued ischemic burden (regardless of PCI or medical therapy) had a significantly increased risk of death or myocardial infarction during follow-up. (20) Recently, the residual SYNTAX score after multivessel PCI was also found to be associated with This study should be interpreted based on several aspects of its design. First, the CART data elements allow identification of additional unrevascularized coronary artery vessels, but current data elements in that dataset do not allow the granular extraction necessary to calculate SYNTAX or residual SYNTAX scores. It is therefore not possible to integrate the overall anatomic details of patients with incomplete anatomic revascularization into a single scoring system. Second, we were able to identify patients with incomplete anatomic revascularization based on visual estimate of a 70% lesion that was not revascularized, but not necessarily residual ischemia. Operator visual assessment is known to potentially overestimate the severity of stenosis when compared to more quantitative methods. Additionally, identification of residual ischemia would require stress imaging or invasive FFR technology to determine the extent of M A N U S C R I P T
13 jeopardized myocardium. While incomplete anatomic revascularization is therefore a proxy for residual ischemia, the significant association between the number of vessels with incomplete revascularization and the risk of postoperative MI supports this association between incomplete revascularization and the presumed extent of residual ischemia. Third, the CART data elements do not provide data on aspirin doing or refills, nor were we able to obtain detailed information on clopidogrel usage post-PCI and in the peri-operative period. It is therefore possible that other patient-related or prescribing patterns contributed to the some of the observed association between incomplete revascularization and postoperative outcomes. Fourth, we do not have data on the clinical decision making to perform complete vs. incomplete revascularization, patient anginal symptoms prior to surgery, the mechanisms of post-operative MI, and whether such events were primarily Type 2 (i.e., demand-related), due to plaque rupture, or due to stent thrombosis. However, recent data has suggested that type 2 MI are associated with similarly poor long-term prognosis, suggesting that this is a clinically important endpoint in this patient population. Fifth, we do not have data on patients who underwent PCI and for whom surgery was ultimately deferred, as the cohort was defined by patients who underwent PCI and then subsequent noncardiac surgery. It is possible that a group of patients with residual ischemia and who were therefore considered at high risk for postoperative complications had surgery cancelled or delayed beyond two years. Sixth, we do not have data on whether medical therapy was intensified in the perioperative period among patients with prior PCI, and whether this was associated with any change in ischemic burden.
CONCLUSION
In conclusion, incomplete revascularization among patients who have undergone PCI is associated with a significantly increased risk of MACE after noncardiac surgery. Of the MACE M A N U S C R I P T components, postoperative MI has the strongest association for patients with multiple unrevascularized vessels. Future studies should investigate the utility of further risk stratification among patients with incomplete revascularization, and whether complete revascularization is associated with lower rates of postoperative MACE.
PERSPECTIVES WHAT IS KNOWN?
Patients with coronary artery disease and prior PCI frequently undergo non-cardiac surgery. The contribution of incomplete revascularization to adverse outcomes is unknown.
WHAT IS NEW?
In a national cohort of Veterans, patients with coronary artery disease and incomplete revascularization who required subsequent non-cardiac surgery had higher rates of major adverse cardiovascular events and myocardial infarction compared to patients with complete revascularization.
WHAT IS NEXT?
Future studies should investigate the contribution of incomplete revascularization to major adverse cardiovascular events after non-cardiac surgery. 
